EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
The word spotlight on a blue background

Spotlight: April 2025

From new scientific data-sharing initiatives to US drug tariffs, May brought a range of major news to the pharma landscape.

Lilly partners with Alchemab for ALS candidate

Eli Lilly joins forces with Alchemab in a deal worth $415m, expanding its neuroscience pipeline with a novel candidate.

US unveils new universal vaccine platform

Generation Gold Standard is a universal vaccine platform targeting influenza, coronaviruses and future pandemics.
Handshake on green background

Novartis acquires Regulus Therapeutics and potential first-in-class therapeutic

Novartis announces acquisition of Regulus Therapeutics, adding a potential first-in-class miR-17 inhibitor to its renal pipeline.

ViiV, Roche and Gilead lead pharma patient group rankings

ViiV leads the 2024/25 pharma company reputation rankings, with the PatientView report also finding ways to improve.
An illustration of a four leaf clover

Ireland launches landmark childhood cancer genomics study

Ireland has launched its first national clinical genomics study in paediatric oncology.
Handshake on blue background

Boehringer and Tessellate partner to tackle tough cancer targets

Boehringer Ingelheim and Tessellate Bio form a €500m partnership to develop precision therapies.

US pharma tariffs: What they mean for drug prices

US drug tariffs may not hit branded prices hard, but generics and supply chains face disruption. Here’s what pharma leaders need to know.
We’ve noticed you’re accessing
from North/South America.